ABOUT ALAXIA

 
 

A private company incorporated in 2008 with strong skills and multiple patents owned

 

Lyon based, Infectious diseases worldwide excellence pole location

 

Partnership with recognized top EU and US research centers

 

 

 

One aim

 

Development of medicinal products for respiratory diseases

    

1st product of the pipeline coming from our peroxidase platform :              Meveol®   

                

Treatment of Cystic Fibrosis

                             

 

ALAXIA SAS on LinkedIn

Development of a treatment to fight against Cystic Fibrosis
The regulatory preclinical study was co-financed by E.U. Europe is moving in Rhone Alpes with the European Regional Development Fund.